PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
82.32%
Some net income increase while AVGO is negative at -9.60%. John Neff would see a short-term edge over the struggling competitor.
-2.24%
Negative yoy D&A while AVGO is 2.44%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-460.00%
Negative yoy deferred tax while AVGO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
23.08%
Less working capital growth vs. AVGO's 300.00%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-42.86%
Both yoy AR lines negative, with AVGO at -106.67%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-135.09%
Both reduce yoy inventory, with AVGO at -42.86%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
85.25%
Lower AP growth vs. AVGO's 205.88%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
9.62%
Lower 'other working capital' growth vs. AVGO's 121.74%. David Dodd would see fewer unexpected short-term demands on cash.
-50.00%
Negative yoy while AVGO is 150.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
87.22%
Operating cash flow growth above 1.5x AVGO's 3.24%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-15.48%
Negative yoy CapEx while AVGO is 29.85%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-248.32%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
264.42%
Liquidation growth of 264.42% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-638.89%
Both yoy lines negative, with AVGO at -211.11%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
1309.09%
We have mild expansions while AVGO is negative at -10.53%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-24.45%
Negative yoy issuance while AVGO is 80.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-6.19%
We cut yoy buybacks while AVGO is 15.38%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.